Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine-Reference-Cited by-同舟云学术

Antibody Persistence in Adults Two Years after Vaccination with an H1N1 2009 Pandemic Influenza Virus-Like Particle Vaccine

Published:2016-02-26 Issue:2 Volume:11 Page:e0150146
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Valero-Pacheco Nuriban,Pérez-Toledo Marisol,Villasís-Keever Miguel Ángel,Núñez-Valencia Adriana,Boscó-Gárate Ilka,Lozano-Dubernard Bernardo,Lara-Puente Horacio,Espitia Clara,Alpuche-Aranda Celia,Bonifaz Laura C.,Arriaga-Pizano Lourdes,Pastelin-Palacios Rodolfo,Isibasi Armando,López-Macías Constantino

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference60 articles.

1. Influenza;KG Nicholson;Lancet,2003

2. Traditional and new influenza vaccines;SS Wong;Clin Microbiol Rev,2013

3. Virus-like particle (VLP)-based vaccines for pandemic influenza: performance of a VLP vaccine during the 2009 influenza pandemic;C Lopez-Macias;Human vaccines & immunotherapeutics,2012

4. Viral nanoparticles and virus-like particles: platforms for contemporary vaccine design;EM Plummer;Wiley interdisciplinary reviews Nanomedicine and nanobiotechnology,2011

5. Antibody responses to preS components after immunization of children with low doses of BioHepB;K Madalinski;Vaccine,2001

Cited by 26 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Crossprotection Induced by Virus-Like Particles Containing Influenza Dual-Hemagglutinin and M2 Ectodomain;Nanomedicine;2024-03-29

2. Virus‐like particles as powerful vaccination strategy against human viruses;Reviews in Medical Virology;2023-12-20

3. Nanovaccines for Advancing Long-Lasting Immunity against Infectious Diseases;ACS Nano;2023-12-06

4. Protection efficacy of the H1 and H3 bivalent virus-like particle vaccine against swine influenza virus infection;Veterinary Microbiology;2023-05

5. Platforms, advances, and technical challenges in virus-like particles-based vaccines;Frontiers in Immunology;2023-02-09